ArticleJCO precision oncology2019

Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade.

David Casadevall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.